Human Coxsackievirus B1 (ATCC® VR-687)

Classification: Picornaviridae, Enterovirus, Human enterovirus B  /  Product Format: frozen

Classification Picornaviridae, Enterovirus, Human enterovirus B
Deposited As Coxsackievirus B1
Agent Human Coxsackievirus B1
Strain HA antigen 201468
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Isolation
Rectal swab from man
Product Format frozen
Storage Conditions -60°C or colder
Comments
Hemagglutinating strain.
Effect on Host
hemagglutination of human (type O, Rh+) RBC (0.5%)
Recommended Host
monkey kidney cells
monkey kidney in tissue culture; suckling mouse
Growth Conditions
Temperature: 37°C
Incubation: 7 days
Effect on Host
hemagglutination of human (type O, Rh+) RBC (0.5%)
Name of Depositor NIH/NIAID
Source
Rectal swab from man
References

Sabin AB, et al. Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses. JAMA 173: 1521-1526, 1960. PubMed: 14440553

Kern J, Rosen L. Identification of enteroviruses by hemagglutination-inhibition. J. Bacteriol. 91: 1936-1942, 1966. PubMed: 4287075

Cross References

Nucleotide (GenBank) : AJ295193 Human coxsackievirus B1 genomic RNA for partial polyprotein gene, isolate VR-687, ATCC.